Human CD69/CLEC2C ORF/cDNA clone-Adenovirus plasmid (BC007037)
Cat. No.: pGMAP000449
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human CD69/CLEC2C adenoviral expression plasmid for CD69 adenovirus packaging, CD69 adenovirus.
Our GM-Adenovirus vector is optimized with the GMVC-modified Adeasy adenovirus packaging system. Find more about the GMVC-modified adenovirus packaging system.
Go to
CD69/CLEC2C products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMAP000449 |
| Gene Name | CD69 |
| Accession Number | BC007037 |
| Gene ID | 969 |
| Species | Human |
| Product Type | Adenovirus plasmid (overexpression) |
| Insert Length | 600 bp |
| Gene Alias | CLEC2C |
| Fluorescent Reporter | GFP |
| Mammalian Cell Selection | Null |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | EF1 |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGAGCTCTGAAAATTGTTTCGTAGCAGAGAACAGCTCTTTGCATCCGGAGAGTGGACAAGAAAATGATGCCACCAGTCCCCATTTCTCAACACGTCATGAAGGGTCCTTCCAAGTTCCTGTCCTGTGTGCTGTAATGAATGTGGTCTTCATCACCATTTTAATCATAGCTCTCATTGCCTTATCAGTGGGCCAATACAATTGTCCAGGCCAATACACATTCTCAATGCCATCAGACAGCCATGTTTCTTCATGCTCTGAGGACTGGGTTGGCTACCAGAGGAAATGCTACTTTATTTCTACTGTGAAGAGGAGCTGGACTTCAGCCCAAAATGCTTGTTCTGAACATGGTGCTACTCTTGCTGTCATTGATTCTGAAAAGGACATGAACTTTCTAAAACGATACGCAGGTAGAGAGGAACACTGGGTTGGACTGAAAAAGGAACCTGGTCACCCATGGAAGTGGTCAAATGGCAAAGAATTTAACAACTGGTTCAACGTTACAGGGTCTGACAAGTGTGTTTTTCTGAAAAACACAGAGGTCAGCAGCATGGAATGTGAGAAGAATTTATACTGGATATGTAACAAACCTTACAAATAA |
| ORF Protein Sequence | MSSENCFVAENSSLHPESGQENDATSPHFSTRHEGSFQVPVLCAVMNVVFITILIIALIALSVGQYNCPGQYTFSMPSDSHVSSCSEDWVGYQRKCYFISTVKRSWTSAQNACSEHGATLAVIDSEKDMNFLKRYAGREEHWVGLKKEPGHPWKWSNGKEFNNWFNVTGSDKCVFLKNTEVSSMECEKNLYWICNKPYK |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-IP0188-Ab | Anti-CD69 monoclonal antibody |
| Target Antigen | GM-Tg-g-IP0188-Ag | CD69 protein |
| ORF Viral Vector | pGMLP000408 | Human CD69 Lentivirus plasmid |
| ORF Viral Vector | pGMAP000449 | Human CD69 Adenovirus plasmid |
| ORF Viral Vector | vGMLP000408 | Human CD69 Lentivirus particle |
| ORF Viral Vector | vGMAP000449 | Human CD69 Adenovirus particle |
Target information
| Target ID | GM-IP0188 |
| Target Name | CD69 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
969 |
| Gene ID |
100053615 (Equus caballus), 101082498 (Felis catus), 281058 (Bos taurus), 29187 (Rattus norvegicus) 477698 (Canis lupus familiaris), 717288 (Macaca mulatta), 969 (Homo sapiens) |
| Gene Symbols & Synonyms | CD69,Cd69,AIM,EA1,MLR-3,CLEC2C,GP32/28,BL-AC/P26 |
| Target Alternative Names | AIM,Activation inducer molecule (AIM),BL-AC/P26,C-type lectin domain family 2 member C,CD69,CLEC2C,Cd69,EA1,Early T-cell activation antigen p60,Early activation antigen CD69,GP32/28,Leukocyte surface antigen Leu-23,MLR-3 |
| Uniprot Accession |
Q07108
Additional SwissProt Accessions: Q07108 |
| Uniprot Entry Name | |
| Protein Sub-location | Introcelluar Protein |
| Category | |
| Disease | cancer |
| Disease from KEGG | |
| Gene Ensembl | ENSECAG00000023027, ENSBTAG00000002135, ENSCAFG00845027879, ENSMMUG00000015297, ENSG00000110848 |
| Target Classification | Tumor-associated antigen (TAA) |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


